Click on image to view larger version.

Figure 4 Effect of Ramipril on sVCAM-1 and CRP Levels

Treatment with ramipril induced a significant decrease of circulating soluble vascular cell adhesion molecule (sVCAM)-1 (A). However, serum levels of C-reactive protein (CRP) remained unchanged after 4 weeks’ treatment with ramipril (B). *p < 0.01 versus before treatment.